Until the end of the year there are no publication charges for Neuroscience Applied. All publications are free for authors who submit their articles by 31 December 2023.

Neuroscience Applied is ECNP’s fully open-access scientific journal, targeting the intersection between neuroscience, applications and new treatment horizons.

ECNP invites you to nominate a candidate for:

• ECNP Neuropsychopharmacology Award which recognises exceptional research achievements in applied and translational neuroscience.
  
  
• ECNP Lifetime Achievement Award which celebrates outstanding career-long contributions to building the field of applied and translational neuroscience.
  
  
• ECNP Rising Star Award which honours up to three emerging research leaders in applied and translational neuroscience.

Deadline is 13 February 2024 at 23.59 CET (Central European Time).

ECNP is pleased to announce the launch of the ECNP Early Career Academy (ECA). The Academy is designed to identify and foster exceptional young researchers and clinicians in applied and translational neuroscience, and provide a springboard for career-long engagement within ECNP.

As well giving unique opportunities to connect with peers from across Europe, the ECA offers special access to positions in ECNP Networks/Thematic Working Groups (TWG), and opportunities to organise ECA meetings and events. Membership is for a period of five years, with 20 new members admitted in this inaugural intake.

Applications for the first cohort are now open!
Find out about the requirements, the benefits of ECA membership, and how to apply here.

Deadline is 23 January 2024.

ECNP invites companies and organisations involved in clinical and pre-clinical research into, and diagnosis and treatment of, disorders of the brain to contribute to the congress’s educational function. We have several opportunities:

• Industry sessions (application deadline is 17 January 2024)
• Exhibition (initial application deadline is 17 January 2024)
• Group registration (will open on 25 January 2024)
• Group hotel reservation

Registration for virtual participation is open!

‘A roadmap for a new diagnostic framework for mental disorders’, 17-18 March 2024, explores how, by linking the classification of neuropsychiatric disorders to their underlying biology, new pathways might be opened to precision diagnostics and the development of new and better treatments.

All scientists, industry leaders, patient representatives and regulators interested in joining the meeting can participate virtually via access to the virtual platform where all sessions will be livestreamed.

Check the programme and visit this page to find out how to register and what fees apply.
There is no cap on the number of virtual attendees.

Discover the latest recipients of the prestigious ECNP Poster Award, which recognises outstanding contributions at the 36^th ECNP Congress Barcelona.

Two of the 2023 winners are:

• Elisa Serra, Luxembourg, with P.0143 ‘Moving beyond clinical approaches: machine learning on neuroimaging and cognitive features for the differential diagnosis between unipolar and bipolar depression’;
• Deborah Reyes, United Kingdom, with P.0334 ‘Effects of psychedelics on induced pluripotent stem cells — derived neurons’

Get to know these winners through interviews conducted by early career scientist Silvia Bruzzone. Hear about their research journey, the inspiration behind their award-winning posters, and the contributions they aim to make in their respective fields.

Read the interview with Elisa Serra and Deborah Reyes.

Explore the latest insights from the 36^th ECNP Congress 2023 Campfire Session, 'Serotonin and Depression - where do we stand?' through the eyes of Dogukan Koc, an early career researcher of the SEROTONIN and BEYOND EU project.

The session, guided by Philip J. Cowen, delved into a critical analysis of the serotonin theory to look at the relationship between serotonin and depression, the necessity for methodological rigour, the complexities of serotonin receptors, and implications for clinical practice.

SEROTONIN and BEYOND is supported by ECNP.

The EU Project AIMS-2-TRIALS is currently recruiting autistic and non-autistic participants (aged 18 years or over) for our online survey about attitudes towards research and the sharing of research data. The project seeks to learn what kind of data participants would be happy to share, with whom, and how much involvement they would like to have in the process.

The survey is anonymous and takes approximately 20-30 minutes to complete.
To find out more and to access the survey please click here.

AIMS-2-TRIALS is supported by ECNP. 

Call for nominations for the inaugural ALBA-Roche Research Prize on Excellence in Neuroscience 2024 is now open!

Awarded through a new partnership between the ALBA Network and Roche, this prize recognises outstanding contributions by mid-career scientists from underrepresented backgrounds, whose work focuses on the nervous system and may improve our understanding of the causal mechanisms of brain diseases.
More information can be found here.

Deadline: 23 January 2024